PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 113 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $32,716 | -74.8% | 4,634 | -77.7% | 0.00% | -100.0% |
| Q4 2020 | $129,832 | +13.2% | 20,740 | -2.2% | 0.00% | 0.0% |
| Q3 2020 | $114,708 | +2.3% | 21,203 | -1.3% | 0.00% | 0.0% |
| Q2 2020 | $112,089 | -28.8% | 21,473 | +32.4% | 0.00% | -50.0% |
| Q3 2018 | $157,353 | -4.6% | 16,222 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $165,000 | +23.1% | 16,222 | +57.1% | 0.00% | 0.0% |
| Q1 2018 | $134,000 | -27.6% | 10,327 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $185,000 | – | 10,327 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $33,805,000 | 33.22% |
| Abingworth LLP | 1,041,131 | $13,535,000 | 8.41% |
| Roumell Asset Management, LLC | 197,347 | $2,566,000 | 5.65% |
| Trellus Management Company, LLC | 89,700 | $1,166,000 | 2.12% |
| Prosight Management, LP | 148,682 | $1,933,000 | 1.21% |
| Broadfin Capital, LLC | 477,607 | $6,209,000 | 0.97% |
| HIGHLAND CAPITAL MANAGEMENT LP | 959,278 | $12,471,000 | 0.64% |
| ARMISTICE CAPITAL, LLC | 580,000 | $7,540,000 | 0.58% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,500 | $1,346,000 | 0.52% |
| Opus Point Partners Management, LLC | 20,000 | $260,000 | 0.51% |